去中心化科學引發研究革命：VitaDAO 引領潮流

VitaDAO 是去中心化科學 (DeSci) 創新者，率先進行早期長壽研究，以提高預期壽命。利用 Molecule 的 IP-NFT 和 IPT 平台，它資助和開發現實世界中的科學舉措。 IP-NFT 將區塊鏈上的智慧財產權代幣化，而 IPT（智慧財產權代幣）則代表科學智慧財產權的所有權，為社群賦能。 VitaDAO 的首次 IPT 公開發售 VITA-FAST 針對正在進行的自噬研究。

Decentralized Science: Revolutionizing Funding and Collaboration in Scientific Research

去中心化科學：徹底改變科學研究的資助和合作

In the realm of scientific research, the path from groundbreaking discoveries to life-changing innovations is often fraught with obstacles. The "valley of death" looms large, threatening to stifle promising research projects due to a lack of funding and operational challenges. Moreover, even when products reach the market, they are often subject to significant markups.

在科學研究領域，從突破性發現到改變生活的創新的道路常常充滿障礙。由於缺乏資金和營運挑戰，「死亡之谷」赫然出現，有可能扼殺有前途的研究計畫。此外，即使產品進入市場，它們也往往會大幅加價。

Decentralized Science (DeSci) emerges as a paradigm shift, leveraging blockchain technology to establish permissionless and community-controlled platforms for scientific research advancement and management. DeSci empowers researchers to secure funding, document their work, and share access to intellectual property, breaking free from the constraints of traditional grant funding and centralized control.

去中心化科學（DeSci）作為一種典範轉移而出現，利用區塊鏈技術建立一個無需許可和社群控制的平台，以促進科學研究的進步和管理。 DeSci 使研究人員能夠獲得資金、記錄他們的工作並共享智慧財產權，從而擺脫傳統資助和集中控制的限制。

VitaDAO: Spearheading the DeSci Movement

VitaDAO：引領 DeSci 運動

VitaDAO stands as a prominent player in the DeSci landscape, dedicated to funding early-stage longevity research projects. Its community encompasses hundreds of academic scientists, longevity researchers, pharmaceutical giants like Pfizer, and crypto industry heavyweights. Through collaborative voting, members shape VitaDAO's research funding decisions, fostering project incubation and commercialization.

VitaDAO 是 DeSci 領域的重要參與者，致力於資助早期長壽研究計畫。其社群包括數百名學術科學家、長壽研究人員、輝瑞等製藥巨頭以及加密產業重量級人物。透過協作投票，成員制定 VitaDAO 的研究資助決策，促進專案孵化和商業化。

Powered by Molecule, a decentralized biotech protocol, VitaDAO has developed a pioneering platform that empowers researchers with flexible funding options. Molecule facilitates the creation of IP-NFTs, non-fungible tokens that embody full legal intellectual property (IP) rights and data control. Researchers can market these IP-NFTs to DAOs and their communities, generating funding and establishing a decentralized IP governance.

在去中心化生物技術協議 Molecule 的支持下，VitaDAO 開發了一個開創性的平台，為研究人員提供靈活的資助選擇。 Molecule 促進 IP-NFT 的創建，這是體現完全合法智慧財產權 (IP) 和資料控制的不可替代代幣。研究人員可以向 DAO 及其社群推銷這些 IP-NFT，從而籌集資金並建立去中心化的 IP 治理。

IP-NFTs: A Novel Avenue for Research Funding

IP-NFT：研究資助的新途徑

IP-NFTs are transformative instruments that enable researchers to access funding by selling their potential future IP to investors eager to acquire IP rights stemming from the research project. Access to research data is restricted to NFT owners, ensuring secure data access.

IP-NFT 是一種變革性工具，使研究人員能夠透過將其潛在的未來智慧財產權出售給渴望獲得研究計畫智慧財產權的投資者來獲得資金。研究資料的存取僅限於 NFT 所有者，確保資料存取的安全。

Moreover, IP-NFTs can be further tokenized into fungible tokens known as IP tokens (IPTs). These fungible tokens enable researchers to raise funds for their projects while granting governance rights to holders, effectively mimicking the mechanisms of initial coin offerings (ICOs) and initial decentralized offerings (IDOs).

此外，IP-NFT 可以進一步代幣化為可替代代幣，稱為 IP 代幣（IPT）。這些可替代代幣使研究人員能夠為其項目籌集資金，同時授予持有者治理權，有效模仿初始代幣發行（ICO）和初始去中心化發行（IDO）的機制。

IPTs: Funding and Governance Empowerment

IPT：資金與治理賦權

Molecule's technology allows IP-NFT owners to transform their IP-NFTs into IP tokens, creating decentralized IP governance for each research project. The IP DAO, composed of IPT holders, assumes control over the project's IP licensing, financial rights, and management. This governance framework ensures that the public retains control over the drugs and products they ultimately use.

Molecule 的技術允許 IP-NFT 所有者將其 IP-NFT 轉換為 IP 代幣，為每個研究項目創建去中心化的 IP 治理。 IP DAO 由 IPT 持有者組成，負責專案的 IP 許可、財務權利和管理。這個治理框架確保公眾保留對其最終使用的藥品和產品的控制權。

VITA-FAST IPT: A Case Study in Crowdfunding

VITA-FAST IPT：群眾募資案例研究

VitaDAO's initial IPT launch, VITA-FAST, exemplifies the potential of IPTs. This token enables holders to directly support the work of Newcastle University's Korolchuk Lab, which aims to identify compounds that stimulate autophagy and rejuvenate aging cells.

VitaDAO 最初推出的 IPT VITA-FAST 體現了 IPT 的潛力。該代幣使持有者能夠直接支持紐卡斯爾大學 Korolchuk 實驗室的工作，該實驗室旨在識別刺激自噬和恢復衰老細胞活力的化合物。

The VITA-FAST fundraising campaign proved remarkably successful, exceeding its target by a factor of 1700%. This success underscores the feasibility of VitaDAO's technology and the power of improved liquidity to drive funding for specific projects within the VitaDAO ecosystem.

VITA-FAST 募款活動非常成功，超出目標 1700%。這項成功凸顯了 VitaDAO 技術的可行性以及提高流動性以推動 VitaDAO 生態系統內特定專案融資的力量。

VitaDAO's Impact on BioPharma

VitaDAO 對生物製藥的影響

Since its inception, VitaDAO has forged partnerships with leading drug-related research projects. It has reportedly raised over $10 million for human-related research and allocated over $4 million to longevity research. VitaDAO's global reach welcomes participation from individuals worldwide, contributing to its impact on BioPharma.

自成立以來，VitaDAO 已與領先的藥物相關研究計畫建立了合作夥伴關係。據報道，該公司已籌集了超過 1000 萬美元用於人類相關研究，並撥款超過 400 萬美元用於長壽研究。 VitaDAO 的全球影響力歡迎世界各地的個人參與，為其對生物製藥的影響做出貢獻。

Enhancing Collaboration and Liquidity

加強協作和流動性

VitaDAO empowers researchers to document their projects on an immutable blockchain layer through NFTs, providing verifiable proof of ownership. This flexibility fosters collaborations, as researchers can create bounties to incentivize other laboratories to contribute data in exchange for a share of the collectively developed IP.

VitaDAO 使研究人員能夠透過 NFT 在不可變的區塊鏈層上記錄他們的項目，從而提供可驗證的所有權證明。這種靈活性促進了合作，因為研究人員可以設立賞金來激勵其他實驗室貢獻數據，以換取共同開發的智慧財產權的份額。

Through its partnership with bio.xyz, an accelerator and meta-governance platform, VitaDAO enables BioDAOs to fund, govern, and develop tokenized IP from universities, companies, and researchers globally. This collaboration catalyzes a surge of community-led translational science, leveraging shared resources, mentorship, and a suite of legal and smart contracts.

透過與加速器和元治理平台 bio.xyz 的合作，VitaDAO 使 BioDAO 能夠資助、管理和開發來自全球大學、公司和研究人員的代幣化智慧財產權。這種合作利用共享資源、指導以及一套法律和智慧合約，促進了社區主導的轉化科學的蓬勃發展。

Improving Drug Development Quality and Cost-Effectiveness

提高藥物開發品質和成本效益

VitaDAO believes that granting patients and researchers governance over medicines will enhance drug development quality and cost-effectiveness. IPTs facilitate collaboration without sacrificing the commercial incentives that drive progress in traditional entities. By empowering patients and researchers, who are directly invested in effective cures, VitaDAO aims to foster higher quality research at lower costs.

VitaDAO 認為，賦予患者和研究人員對藥物的治理權將提高藥物開發品質和成本效益。 IPT 促進協作，同時又不犧牲推動傳統實體進步的商業激勵措施。透過為直接投資於有效治療的患者和研究人員提供支持，VitaDAO 旨在以更低的成本促進更高品質的研究。

Discoverability of Projects: Bridging the Gap

項目的可發現性：彌合差距

Academic research often faces discoverability challenges, making it difficult for investors to identify promising projects. VitaDAO bridges this gap through its partnership with Molecule, a biopharma IP marketplace. Researchers and biotech companies can showcase their projects and discoveries on Molecule, expanding their reach to a wider network of investors, including VitaDAO. This enhanced discoverability empowers patients and biotech companies to support research projects aligned with their interests.

學術研究經常面臨可發現性的挑戰，使得投資者很難識別有前途的項目。 VitaDAO 透過與生物製藥 IP 市場 Molecule 的合作彌補了這一差距。研究人員和生物技術公司可以在 Molecule 上展示他們的項目和發現，從而將他們的影響力擴大到更廣泛的投資者網絡，包括 VitaDAO。這種增強的可發現性使患者和生物技術公司能夠支持符合他們興趣的研究計畫。

Conclusion: A Shift in Paradigm

結論：範式的轉變

VitaDAO and DeSci herald a groundbreaking shift in scientific research. By embracing decentralization, blockchain technology empowers individuals to reclaim control over research funding, data, and intellectual property. Through IP-NFTs and IPTs, researchers can secure funding and establish community-driven governance for their projects, aligning incentives and fostering collaboration.

VitaDAO 和 DeSci 預示著科學研究的突破性轉變。透過擁抱去中心化，區塊鏈技術使個人能夠重新控制研究經費、數據和智慧財產權。透過 IP-NFT 和 IPT，研究人員可以獲得資金並為其計畫建立社區驅動的治理，調整激勵措施並促進合作。

As the DeSci narrative continues to evolve, it presents exciting possibilities for the future of scientific research. However, it is crucial to exercise due diligence before investing in any project, understanding the mechanisms and associated risks. This article serves as a comprehensive guide to the DeSci movement and VitaDAO's pivotal role, but it is not intended as financial or investment advice.

隨著 DeSci 敘述的不斷發展，它為科學研究的未來提供了令人興奮的可能性。然而，在投資任何項目之前進行盡職調查、了解其機制和相關風險至關重要。本文作為 DeSci 運動和 VitaDAO 關鍵作用的綜合指南，但無意作為財務或投資建議。